Early Phase 1 Breast Cancer Trial, Recruiting NCT05464810 Sponsor: Emory University Condition: Breast Cancer
Back to Breast Cancer

Early Phase 1 Breast Cancer Trial, Recruiting

NCT05464810
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with breast cancer confirmed by biopsy, where the cancer is hormone receptor positive, HER2 negative, and at an early to locally advanced stage (Stage I–III)
  • Your tumor is at least 5 mm in size as seen on a mammogram, ultrasound, or MRI
  • Your tumor shows a certain level of a growth marker called Ki-67 (at least 10%) on lab testing (confirm with trial site)
  • You are post-menopausal — meaning you have had both ovaries removed, are 55 or older, or have not had a period for 12 or more months under specific conditions (confirm with trial site)
  • You are generally able to carry out daily activities (your overall health and functioning meets a standard scale rating of 0–2) (confirm with trial site)
  • You have not received chemotherapy, immunotherapy, hormone therapy, or other experimental treatments in the past 3 months
  • You have not taken cholesterol-lowering medications (statins, fibrates, or ezetimibe) in the past 3 months
  • You do not have active liver disease
  • Your recent blood test results (within the last 14 days) show your blood counts, liver function, and kidney function are within acceptable ranges
  • You are willing and able to attend scheduled visits, take medications as directed, and follow all study requirements
  • You are willing to sign a written consent form to participate

Who may not be able to join:

  • You have taken part in another clinical trial or used an experimental treatment or device within the past 3 months
  • You have had a serious allergic reaction to medications similar to simvastatin (a cholesterol drug) or letrozole (a hormone therapy)
  • You are currently taking certain medications that can interfere with how the study drugs work, including some antibiotics, antifungals, HIV medications, or other specific drugs (confirm with trial site for the full list)
  • You have an uncontrolled ongoing illness, such as an active infection, serious heart problems, substance use disorder, or a mental health condition that could make it hard to follow the study plan
  • You have had a serious heart or blood vessel event (such as a heart attack or stroke) within the past 3 months, or you currently have severe or poorly controlled heart disease or very high blood pressure
  • You have another cancer that is currently growing or requires active treatment (skin cancers that have been successfully treated may be an exception — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Registry
ClinicalTrials.gov
Start date
2 September 2022
Est. completion
15 April 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean percentage change in Ki-67

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov